
Sign up to save your podcasts
Or


Listen in as we discuss considerations, challenges, and strategies related to the use and switching of biosimilars in clinical practice. You’ll hear communication tips to address patient and prescriber concerns as well as operational considerations for integrating biosimilars into practice.
Special guests:
You’ll also hear practical advice from TRC’s Editorial Advisory Board member:
For the purposes of disclosure, Dr. Megan May reports relevant financial relationships [lung cancer] with Amgen, AstraZeneca, Pharmacosmos (speakers bureau). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.
This podcast is an excerpt from one of TRC’s monthly live CE webinars, the full webinar originally aired in August 2025.
TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.
Claim Credit
The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Use code mt1025 at checkout for 10% off a new subscription.
Send a text
Email us: [email protected].
The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.
Learn more about our product offerings at trchealthcare.com.
By TRC Healthcare | Pharmacist's Letter | Prescriber Insights | Pharmacy Technician's Letter4.3
4747 ratings
Listen in as we discuss considerations, challenges, and strategies related to the use and switching of biosimilars in clinical practice. You’ll hear communication tips to address patient and prescriber concerns as well as operational considerations for integrating biosimilars into practice.
Special guests:
You’ll also hear practical advice from TRC’s Editorial Advisory Board member:
For the purposes of disclosure, Dr. Megan May reports relevant financial relationships [lung cancer] with Amgen, AstraZeneca, Pharmacosmos (speakers bureau). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.
This podcast is an excerpt from one of TRC’s monthly live CE webinars, the full webinar originally aired in August 2025.
TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.
Claim Credit
The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Use code mt1025 at checkout for 10% off a new subscription.
Send a text
Email us: [email protected].
The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.
Learn more about our product offerings at trchealthcare.com.

503 Listeners

101 Listeners

3,367 Listeners

731 Listeners

8,035 Listeners

297 Listeners

93 Listeners

10,260 Listeners

375 Listeners

29,273 Listeners

11,029 Listeners

37 Listeners

20,181 Listeners

3 Listeners

6 Listeners